Ensemble Innovation Ventures

What Ensemble Innovation Ventures does

Ensemble Innovation Ventures is a Denver-area venture capital fund founded in 2020 that makes minority equity investments in U.S.-headquartered early-stage healthcare and wellness companies. The fund is headquartered at 8300 Arista Place, Suite 300, Broomfield, Colorado, and concentrates its sourcing primarily on the Intermountain West region while remaining open to opportunities elsewhere in the United States. Its investment team consists of three core professionals: Managing Director Helen Drexler (former President & CEO of Delta Dental of Colorado), Brian Armstrong (30+ years of capital markets experience, formerly a founding partner of Point B Capital), and Associate Principal Shannon Flahive (early-stage investing background spanning Blackhorn Ventures, Service Provider Capital, and the University of Colorado's Deming Center Venture Fund).

The fund's core activity is capital deployment into healthcare and wellness startups, with initial checks of up to $1 million targeted at companies with approximately $1 million in run-rate revenue, alongside reserves for follow-on participation. Ensemble takes board observer seats (or director seats when appropriate) and requires information rights, embedding itself in governance alongside other institutional co-investors. The disclosed portfolio spans at least 15 companies across diverse verticals including virtual cardiology (Auxira Health), oncology workflow AI (Spiraldot Health), dental AI diagnostics (VideaHealth), health equity platforms (TruLite Health), hearing care (Yes Hearing), and benefits administration (Nexben). The fund partners academically with the University of Colorado's Deming Center Venture Fund and participates in the regional venture ecosystem through the Rocky Mountain Venture Capital Association.

The fund generates returns through equity ownership in portfolio companies, with value creation driven by board participation, follow-on investment, and eventual exits via acquisition or IPO. Its competitive positioning rests on combining capital with healthcare operating expertise and regional proximity advantages in the Intermountain West, where it operates as a relationship-driven syndicate partner to larger institutional VCs. No fund size, AUM, LP composition, or revenue figures have been publicly disclosed.

Name

Ensemble Innovation Ventures

Legal name

Ensemble Innovation Ventures

Website

https://ensembleinnovationventures.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Ensemble Innovation Ventures is a Broomfield, Colorado-based early-stage venture capital fund founded in 2020 that invests up to $1 million in U.S.-headquartered healthcare and wellness startups, primarily across the Intermountain West, taking minority equity stakes and board observer seats alongside institutional co-investors.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Miscellaneous Financial Investment Activities (523999), Other Financial Vehicles (525990)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

akta.pro secondary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Venture capital investing
• Early-stage investments
• Healthcare venture funding
• Minority equity stakes
• Startup capital funding

Headquarters

HQ city

Denver

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Venture Capital Fund Management: The fund generates returns through equity ownership positions in early-stage healthcare and wellness companies. Returns are realized through follow-on investments, board participation, and eventual exits via acquisition or IPO.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Ensemble Innovation Ventures operates the Ensemble Innovation Ventures Fund, an early-stage venture capital fund that makes minority ownership investments in U.S.-headquartered healthcare and wellness startups. The fund typically invests up to $1 million initially in companies with at least $1 million in run rate revenue, reserves capital for follow-on investments, and takes board observer or director seats alongside information rights. Returns are generated through follow-on participation, board engagement, and eventual exits via acquisition or IPO.

Differentiator

Problem solved

Functional benefit

Products and services

• Ensemble Innovation Ventures Fund Early-stage venture capital fund that makes minority ownership investments of up to $1 million in U.S.-headquartered healthcare and wellness startups, typically those with at least $1 million in run rate revenue, with reserves for follow-on rounds. The fund takes board observer or director seats and information rights, and couples capital with healthcare industry expertise and syndicate co-investor access.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered minor.

• Deming Center Venture FundminorStrategic or Co-development PartnerAcademic partnership with University of Colorado's Deming Center Venture Fund. Team member Shannon Flahive previously worked with the fund during her MBA program. Collaboration on venture ecosystem building and student engagement.
• Rocky Mountain Venture Capital Association (RMVCA)minorStrategic or Co-development PartnerBrian Armstrong served on the board of RMVCA, indicating active participation in the regional venture capital community for networking and ecosystem development.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Route 66 Ventures: Early-stage healthcare-focused VC. Co-led Auxira Health's $7.8M seed round alongside Ensemble in December 2025, demonstrating direct co-investment activity in the same digital health subsector.
• Abundant Venture Partners: Early-stage venture firm with a healthcare and technology focus. Co-led the Auxira Health seed with Ensemble and Route 66 Ventures, operating as a direct syndicate partner.
• Rock Health: Pioneer digital health venture fund and advisory. Directly comparable as a healthcare/digital-health focused early-stage investor with a similar thesis on technology-enabled care delivery.
• Blackhorn Ventures: Early-stage industrial and enterprise-tech focused VC where Ensemble team member Shannon Flahive previously worked. Comparable as a small, thesis-driven early-stage fund.
• Springboard Health Angels: Network of angel and early-stage investors focused specifically on healthcare and life sciences. Directly comparable thesis (early-stage healthcare investing) with similar check sizes and regional activity.
• AV8 Ventures: Early-stage venture firm investing across healthcare, fintech, and frontier tech. Comparable check sizes and early-stage focus, with overlapping healthcare and digital health investments.
• Point B Capital: Corporate venture capital fund where Brian Armstrong was a founding partner. Directly comparable early-stage CVC model with similar stage focus and check sizing approach.

Broad incumbents

• Techstars: Large global accelerator and early-stage investor with active healthcare programs. Operates as a much larger incumbent in the same early-stage healthcare ecosystem where Ensemble plays.

Regional players

• Rockies Venture Fund: Colorado-based early-stage VC focused on the Rocky Mountain/Intermountain region. Directly comparable to Ensemble on geography and stage, though with broader sector exposure beyond healthcare.

Emerging players

• Cedars-Sinai Accelerator: Health-system-affiliated accelerator investing in early-stage healthcare startups. Comparable as a healthcare-specific early-stage capital provider with operating-partner value-add.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ensemble-innovation-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ensemble Innovation Ventures